Biobricks

  1. Urinary tract infections, Uro-pathogens and their associated virulence factors
  2. Urinary tract infections (UTIs) are one of the most common pathological conditions in both community and hospital settings. It has been estimated that about 150 million people worldwide develop UTI each year. Among the common uropathogens associated with UTIs, UroPathogenic Escherichia coli (UPEC) is the primary cause. UPEC strains possess a plethora of both structural (as fimbriae, pili, curli, flagella) and secreted (toxins, iron-acquisition systems) virulence factors that contribute to their capacity to cause disease, although the ability to adhere to host epithelial cells in the urinary tract represents the most important determinant of pathogenicity.7 Among the large variety of bacterial adhering factors (adhesins) that promote adhesion and internalization into host cells, type 1 fimbriae are remarkably versatile virulence factors. Therefore our project is primarily focused on the Type 1 fimbriae, since it is commonly found in most of the UPECs and other uropathogens.8

    Image

  3. Type 1 fimbriae: the virulence factor
  4. Type 1 fimbriae, specifically helps the uropathogens to adhere to a spectrum of alpha-D-mannosides found in mammalian tissue surface. It has a 7nm wide and 1 μm long heteropolymer structure, out of which approximately 1000 copies are of the major subunit, FimA,that are polymerised into a right-handed helical structure. Additionally it also contains a few percent of the minor components FimF, FimG and FimH. 1

    The functions of the components of Type 1 fimbriae are:

    1. FimH acts as a receptor- recognition element of type 1 fimbriae . It is located at the tip of the organelle as an integral part of a short fibrillum.
    2. FimF and FimG proteins act as adapters for integration of adhesins into the fimbrial organelle.
    3. FimC and FimD are the proteins used to assemble fimbriae on the surface of the cell.1

    Since FimH is the main protein interacting with the alpha D mannoside receptors of the host cell , our project aims to use FimH as a bait to detect Uropathogens using a combination of aptamers that show high affinity towards FimH.

  5. FimH - the target protein
  6. FimH is the mannose-binding adhesin found at the tip of the type 1 pilus produced by UPEC. It is a two-domain protein in which the N-terminal domain contains the receptor-binding site and the C-terminal domain is required for organelle integration.1 The interaction between these two domains, determines the conformational state of the FimH adhesin, and therefore influencing the level of affinity of FimH with the related molecule/receptor/ligand. The conformation of FimH is highly dynamic, and interdomain interactions can be influenced by different factors, including the shear stress.9 Besides UPEC, many other uropathogens also express FimH as their virulence factor.8

    The figure shows the 3 dimensional cartoon representation of FimH structure containing the two primary domains -The N-terminal domain or lectin domain (depicted in cyan) that is required for receptor-binding and the C-terminal domain or the pillin domain (depicted in blue) which is required for organelle integration. An elongated linker (in orange) connects the pilin and the lectin domain of FimH. The protein is bound to alpha D mannose molecule that is depicted as atom colored Vanderwaal spheres.(Adapted from EvaMaria Krammer et al., Molecules 2018)10

    Image

      Basic Parts

      These are the parts of our cloned constructs that will be generated in our project Apt4UTI:

      Serial Description Part Number Type Length(bp)
      1 Expression of FimH1 gene BBa_K4449000 Coding 540
      2 Expression of FimH2 gene BBa_K4449001 Coding 534
      3 Expression of Staphylococcus epidermidis Bap like Bhp gene BBa_K4449002 Coding 6909
      4 pET28b FimH1 F BBa_K4449003 Primer 32
      5 pET28b FimH1 R BBa_K4449004 Primer 30
      6 pET15b FimH2 F BBa_K4449005 Primer 29
      7 pET15b FimH2 R BBa_K4449006 Primer 29
      8 pET28b Bhp F BBa_K4449007 Primer 28
      9 pET28b Bhp R BBa_K4449008 Primer 28
      10 Aptamer Sequences BBa_K4449012 DNA 80

      FimH1 and FimH2

      Both FimH1 and FimH2 primarily contains the coding sequence of the FimH gene retrieved from the plasmid pBAD - FimH -9X His that is deposited in the Addgene repository (Addgene # 97305) by Per Svenningsen Lab.

      But, in order to clone the FimH gene in two different vectors some modifications had been done in the sequences to maintain the reading frame and hence we have two sequences FimH1 and FimH2, without affecting their functionality.

      Here FimH1(BBa_K4449000) is cloned in the pET28b+ vector between Nco1f and Xho 1 sites to generate the construct Apt4UTI C1 (BBa_K4449009). Again, the FimH2 (BBa_K4449001) gene was cloned between the BamH1 and Blp1 sites of pET15b vector to generate the construct Apt4UTI C2 (BBa_K4449010).

      Aptamer Sequences

      We have generated our own aptamer library which will be utilized in the subsequent rounds of the ligand based SELEX , to select for the best aptamer candidates that will show highest affinity towards FimH1 and FimH2 . This library is characterized by the presence of 40 random nucleotides in between flanked by a common known 5’ and 3’ sequences on both sides which will act as the primer binding sites . These known sequences were added so that the selected aptamer sequences can be subjected to PCR amplification in the positive selection rounds of SELEX technique.

      The aptamer sequences were generated using python with the help of Jupyter Notebook.2

      Image

      Here are the list of generated Aptamer Sequences: Click Here

      The given script was used to generate the output:

      list_1 = [ ]

      for y in range(0,500):

      s = "AAAAAAAAAAAACCCCCCCCCCCCGGGGGGGGTTTTTTTT"

      t = ''.join(random.sample(s,len(s)))"

      list_1.append(t)

      print(list_1)

      Composite parts

      These are the proposed parts that will be generated in our project Apt4UTI:

      Serial number Description Part Number Components Stratergy Type Length(bp)
      1 Apt4UTI C1 BBa_K4449009
      1. BBa_K3830009
      2. BBa_K389005
      3. BBa_K4103004
      4. BBa_K4047028
      5. BBa_K2259010
      6. BBa_K082004
      7. BBa_K3842018
      8. BBa_I719005
      9. BBa_K4284000
      10. BBa_K4159001
      11. BBa_K4449000
      12. BBa_K1362468
      13. BBa_K731721

      Cloning the gene encoding the FimH1(BBa_K4449000) obtained from modifying the FimH gene from plasmid pBAD-FimH-9XHis (Addgene plasmid #97305) into pET28b+ (EMD Biosciences) expression vector between the Nco1 and Xho1 restriction sites.

      Composite 5773
      2 Apt4UTI C2 BBa_K4449010
      1. BBa_K3982027
      2. BBa_K4284007
      3. BBa_K4103004
      4. BBa_K2259010
      5. BBa_K082004
      6. BBa_K3842018
      7. BBa_I719005
      8. BBa_K4284000
      9. BBa_K4159001
      10. BBa_K1362468
      11. BBa_K1362456
      12. BBa_K4449001
      13. BBa_K731721

      Cloning the gene FimH2(BBa_K4449001) (gene sequence obtained from modifying the FimH gene from plasmid pBAD-FimH-9XHis Addgene plasmid #97305) into pET15b (Novagen) expression vector between the Bam H1 and Blp1 restriction sites.

      Composite 6197
      3 Apt4UTI C3 BBa_K4449011
      1. BBa_K3830009
      2. BBa_K389005
      3. BBa_K4103004
      4. BBa_K4047028
      5. BBa_K2259010
      6. BBa_K082004
      7. BBa_K3842018
      8. BBa_I719005
      9. BBa_K4284000
      10. BBa_K2685025
      11. BBa_K4449002
      12. BBa_K1362468
      13. BBa_K731721

      Cloning the gene encoding Staphylococcus epidermidis Bap like Bhp (BBa_K4449002)( coding sequence obtained from European Nucleotide Archive browser) in pET28b+ expression vector (EMD Biosciences) between the Nco1 and Xho1 restriction sites.

      Composite 12136

    1. Apt4UTI C1
    2. The DNA insert, FimH1 (BBa_K4449000) in this construct Apt4UTI C1(BBa_K4449001) contains the coding sequence of the E.coli UTI89 FimH signal peptide and lectin domain which forms a subunit of Type 1 fimbriae, located at the tip of the organelle as an integral part of short fimbriae. This construct will enable the expression of a C terminal -6 X His tagged FimH1 protein which will be purified by a Ni-NTA affinity column and will subsequently be used for conducting experiments like SDS PAGE, Receptor Blots and ELISA Based binding assays. The expressed protein, FimH1-6XHis (target) will be also tested with our aptamer library during the ligand based SELEX technique to find out the aptamer showing highest affinity towards the target. The construct map was created by using SnapGene.

      To know more related to testing of this part visit Contribution Page

      Image

    3. Apt4UTI C2
    4. The DNA insert FimH2 in this construct contains the coding sequence of the E.coli UTI89 FimH signal peptide and lectin domain which forms a subunit of type 1 fimbriae, located at the tip of the organelle as an integral part of short fimbriae. This construct will enable the expression of a N terminal -6 X His tagged FimH2 protein with a thrombin site which will be purified by a Ni-NTA affinity column and will subsequently be used for conducting experiments like SDS PAGE, Receptor Blots and ELISA Based binding assays. The thrombin site will be used to remove the 6X His tag by using the thrombin enzyme which cleaves between the Arginine and Glycine residue. This composite part will enable us to validate if our candidate aptamers are truly binding to the purified FimH2 protein and are showing no interaction with the His Tag. By designing this construct we will be setting up a platform to purify tag free FimH protein. The expressed protein, FimH2 (target) will be also tested with our generated aptamer library during the ligand based SELEX technique to find out the aptamer showing highest affinity. The construct map was created by using SnapGene.

      To know more related to testing of this part visit Contribution Page

      Image

    5. Apt4UTI C3
    6. The DNA insert (Bap like Bhp) in this construct Apt4UTI C3 encodes a virulence factor of S. epidermidis that helps in biofilm accumulation is Bap (biofilm associated protein) which is known as a surface adhesion protein that is commonly found in S. epidermidis strains.3 This construct will enable the expression of Bhp protein with a C terminal 6X His tag in E Coli strain BL21DE3. The expressed fusion protein will subsequently be purified by using the Ni-NTA affinity column due to the presence of the His tag. Bhp will be used for the negative selection round of ligand based SELEX and will serve as a negative control in our ELISA based binding assays. We have chosen this part from Staphylococcus epidermis because Staphylococcus epidermidis comprises a minority of the microflora of the lower part of the Urethra , and can be expected to be present as a contaminant in the urine cultures.4 experiments like SDS PAGE, Receptor blots and ELISA based binding assays will be conducted for testing this part. The construct map was created by using SnapGene.

      Image

      Existing parts

      The following existing parts will be used in our project:

      Biobrick Part Number
      f1 ori BBa_K3830009
      KanR BBa_K389005
      ori BBa_K4103004
      bom BBa_K4047028
      rop BBa_K2259010
      lacI BBa_K082004
      lacI promotor BBa_K3842018
      T7 promoter BBa_I719005
      lac operator BBa_K4284000
      RBS BBa_K2685025
      6x His BBa_K1362468
      T7 terminator BBa_K731721
      Thrombin site BBa_K1362456
      AmpR promoter BBa_K3982027
      Amp R BBa_K4284007

References:

  1. Schembri, M.A., Hasman, H. and Klemm, P. (2000). Expression and purification of the mannose recognition domain of the FimH adhesin. FEMS Microbiology Letters, 188(2), pp.147–151.DOI: 10.1111/j.1574-6968.2000.tb09186.x
  2. Tao Wang , Wang Yin,Hadi AlShamaileh, Yumei Zhang, Phuong Ha-Lien Tran, Tuong Ngoc-Gia Nguyen, Yong Li, Kuisheng Chen, Miaomiao Sun, Yingchun Hou, Weihong Zhang, Qingxia Zhao, Changying Chen, Pei-Zhuo Zhang, and Wei Duan, 2019 Feb; 30(1), A detailed protein-SELEX protocol allowing visual assessments of individual steps for high success rate, DOI: 10.1089/hgtb.2018.237
  3. Amirmorteza ,EbrahimzadehNamvar,Sara Bastarahang,Niloufar Abbasi,Ghazaleh Sheikhi,Ghehi ,Sara,Farhadbakhtiarian,Parastoo Arezi,Mahsa Hosseini,Sholeh Zaeemi Baravati, Zahra Jokar,Sara Ganji Chermahin ,Clinical characteristics of Staphylococcus epidermidis: a systematic review ,2014 Sep 30, GMS Hygiene and Infection Control 2014, Vol. 9(3), DOI: 10.3205/dgkh000243
  4. Shankar Upadhyayula, Mamatha Kambalapalli, and Basim . Asmar, Staphylococcus epidermidis Urinary Tract Infection in an Infants;24 July 2012,Case Reports in Infectious Disease,Volume 2012, Article ID 983153. DOI:10.1155/2012/983153
  5. Meysam Sarshar , Payam Behzadi , Cecilia Ambrosi , Carlo Zagaglia , Anna Teresa Palamara ,and Daniela Scribano ,FimH and Anti-Adhesive Therapeutics: A Disarming Strategy Against Uropathogen,10 July 2020,Antibiotics (Basel), 10.3390/antibiotics9070397
  6. Terlizzi, M.E. , Gribaudo, G. , and Maffei, M.E. ‘UroPathogenic Escherichia coli (UPEC) Infections: Virulence Factors, Bladder Responses, Antibiotic, and Non-antibiotic Antimicrobial Strategies.’,2017 DOI: 10.3389/fmicb.2017.01566
  7. Meysam Sarshar,Payam Behzadi, Cecilia Ambrosi,Carlo Zagaglia,Anna Teresa Palamara, and Daniela Scribano , FimH and Anti-Adhesive Therapeutics: A Disarming Strategy Against Uropathogens, 2020 Jul 10,Antibiotics (Basel). Doi: 10.3390/antibiotics9070397
  8. Pavel Aprikia , Veronika Tchesnokova, Brian Kidd , Olga Yakovenko, Vladimir Yarov-Yarovoy , Elena Trinchina , Viola Vogel , Wendy Thomas , and Evgeni Sokurenko,Interdomain Interaction in the FimH Adhesin of Escherichia coli Regulates the Affinity to Mannose,March 8, 2007,THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 282, NO. 32, pp. 23437–23446, DOI:10.1074/jbc.M702037200Doi
  9. Eva Maria Krammer,Jerome D Ruyck,Goedele Roos, Julie Bouckaert,Mark.F.Lensink; Targeting Dynamical Binding Processes in the Design of Non-Antibiotic Anti-Adhesives by Molecular Simulation—The Example of FimH ;5 July 2018,MDPI, Doi: 10.3390/molecules23071641
  10. Roger D Klein , Scott J Hultgren ;Urinary tract infections: microbial pathogenesis, host-pathogen interactions and new treatment strategies;2020 Apr;18(4);Nat Rev Microbiol
  11. G Godaly , C Svanborg;Urinary tract infections revisited;2007 Apr7;Kidney Int
Image
Image
Image
Image
Image
Image
Loading...